Solutions that shape technological progress

Diagnose & Treat

Researching into Micro- and Nanostructures

See better

Assure Industrial Quality Excellence

Enabling Chip Manufacturers

Photograph & Film

Latest on the COVID-19 Situation

In response to the coronavirus pandemic, ZEISS has taken comprehensive measures to protect employees and maintain smart business continuity.

In order to continue supporting customers and partners as best as possible, at ZEISS we are doing everything we can to protect our employees’ health and safety as well as maintain production in our plants and ensure our service operations.

In January, ZEISS set up a dedicated task force. We are closely assessing the latest developments together with government agencies and healthcare authorities on an ongoing basis. Decisions are made daily regarding the most sensible measures for ZEISS to take.

Of course, we will continue to be available for our customers as best we can. Some employees in individual areas are currently working remotely but can still be reached at their usual phone numbers and email addresses.

However, should our customers experience any disruptions in service at some of our sites and sales offices, we can also be contacted on these numbers.

All over the world, the company and its employees are joining the fight against the spread and consequences of the coronavirus pandemic. Read more

Discover ZEISS

Fascinating insights into the world of optics

World Cancer Day

The role of ZEISS in fighting cancer

More than Just a Pair of Glasses:

How ZEISS Lenses Influenced Monet`s Creative Process

News & Events

News from the ZEISS Group

10 June 2021

ZEISS Symposium 2021: Optical Technologies Drive Medical Innovation

Press Release

Global healthcare systems are under enormous pressure to provide modern medical care to the world's growing and aging population. This can only be solved through future-ready, innovative and efficient technologies.

9 June 2021

ZEISS Innovation Hub in Dresden Opens Its Doors

Press Release

In late May, the team at the ZEISS Innovation Hub in Dresden got down to work. An official opening ceremony for the Hub will take place once it is permissible to do so. For the first Hub program – research into organoid models – Dr. Kai Wicker and his team have moved into the EKFZ for Digital Health on the campus of the Carl Gustav Carus University Hospital – a stone's throw away from top experts in the field.

19 May 2021

Half-Year Figures: ZEISS Reports Successful Start to Fiscal Year

Press Release

The ZEISS Group had a successful end to the first six months of fiscal year 2020/21. It saw its revenue rise by 6 percent (adjusted for currency fluctuations, by 9 percent) to 3.406 billion euros. At 591 million euros, earnings before interest and tax (EBIT) were significantly higher than in the previous year (455 million euros). The EBIT margin was 17%. Incoming orders increased to 4.200 billion euros.